Friday 29 August 2008

Race-Based Medications, Supplements 'Misleading,' Opinion Piece Says


The "developing of race-based products such as vitamins and drugs" by pharmaceutical manufacturers is "misleading the public to believe that races ar biologically distinguishable, requiring race-specific products, only the foundation for their wares flies in the face of science," Susanne Haga, an assistant enquiry professor at Duke University's Institute for Genome Sciences Policy and Public Policy, writes in a Durham Herald Sun opinion piece. According to Haga, "While there ar some differences in disease prevalence among races, there are no diseases or conditions -- and sure no nutritional requirements -- that are exclusive to just one group." She adds, "If we've erudite anything from the final decade of genetics research, it's that our DNA is loosely colorblind."

Nubian Health Products and GenSpec offer vitamins and/or dietary supplements specifically for blacks, and NitroMed developed the heart disease treatment BiDil, the first FDA-approved raced-based drug, she notes. "As a genetic science researcher and someone of mixed heritage myself, these companies contemplate a perturbing trend," Haga writes.

She continues, "Given the wide variation within groups, the development of a 'genetically specific' formula would be intriguing, to state the least," adding, "The recent increase in the numbers of people wHO identify with more than one subspecies would look to pose a quite large trouble to the companies marketing race-based products."

Haga writes, "Although genetics is involved in most if not all aspects of our health, the environment plays at least an match role," adding, "Even if we knew which genes played a part in our dietary needs, it's unlikely those differences would follow perceived racial divides." The industry needs to "look beyond skin color" in the development of personalized music, Haga writes (Haga, Durham Herald Sun, 8/22).


A "Today's Topics in Health Disparities" webcast on "Race and Genetics: The Future of Personalized Medicine" is available online.


Reprinted with kind permission from hTTP://www.kaisernetwork.org. You can eyeshot the intact Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at hTTP://www.kaisernetwork.